You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康2022年度業績盈喜預期:總收入持續三倍高速增長 毛利率大幅提升逾80%
格隆匯 01-12 17:04
格隆匯1月12日丨諾輝健康(6606.HK)今日盤後發佈2022年度業績盈喜預期,據未經審計的經營數據,截至2022年12月31日,公司年度總收入預期介於人民幣750.5百萬元至人民幣782.5百萬元,較2021年同期增長區間為252.7%至267.7%;年度毛利預期介於人民幣638.8百萬元至人民幣656.3百萬元,較2021年同期增長區間為313.2%至324.5%;年度毛利率預期介於81.6%至87.4%。 公吿顯示,收入總額及毛利增加主要歸功於常衞清及噗噗管的收入及毛利增加及於2022年1月新產品幽幽管的上市。公司醫院渠道已成為“中國癌症早篩第一證”產品常衞清最大的收入來源和增長最快的渠道。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account